Patent ID: 11857697
Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 2:
3. The method of claim 2,
wherein the small molecule or agonist that activates the Wnt signaling pathway is CHIR99021,
wherein the small molecule or agonist that activates the FGF signaling pathway is selected from FGF1, FGF2, FGF3, FGF4, FGF10, FGF11, FGF12, FGF13, FGF14, FGF15, FGF16, FGF17, FGF18, FGF19, FGF20, FGF21, FGF22, and FGF23,
wherein the small molecule or agonist that activates the RA signaling pathway is selected from the group consisting of all-trans retinoic acid, AC 261066, AC 55649, adapalene, AM 580, AM 80, BMS 753, BMS 961, CD 1530, CD 2314, CD 437, Ch 55, isotretinoin, tazarotene, and TTNPB.